http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107496921-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49f0920dbf4baf180654f61d90d77ff5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
filingDate 2017-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73bc6b966a144eff471e7845e797842c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d601c8c1a56bf747e06856f76d3860f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6b48ab6b2aa7b997066266041030202
publicationDate 2017-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107496921-A
titleOfInvention Sema3E/PlexinD1 signal paths target drug is preparing the application in suppressing Neointimal formation medicine
abstract The invention discloses using application of the Sema3E/PlexinD1 signal paths as the medicine of target spot in the medicine for suppressing Neointimal formation is prepared, it is found by the applicant that Sema3E/PlexinD1 signal paths, which can act on smooth muscle cell, suppresses its proliferation apoptosis, on the one hand by suppressing endothelial cell platelet derived growth factor(PDGF)Generation, on the other hand by activating Sema3E/PlexinD1 downstream signaling pathways, double action significantly inhibits smooth muscle cell proliferation migration so as to suppress Neointimal formation, and new thinking is provided for vascular proliferative diseases such as atherosclerosis, the postoperative ISRs of stenter to implant.
priorityDate 2017-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11547
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13717
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2006
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15502
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP54320
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04985
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID103183906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453947315
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25043
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07916
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ99372

Total number of triples: 27.